Bruker Corp. Aktie
Bruker Corp. Aktie
Was spricht für und gegen Bruker Corp. in den nächsten Jahren?
Pro
Kontra
Rendite von Bruker Corp. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | 2,78 % | 0,85 % | 4,48 % | -10,60 % | -23,31 % | -56,56 % | - |
| Healthequity Inc. | 0,72 % | 5,30 % | -1,42 % | -6,08 % | -10,90 % | 43,00 % | 10,88 % |
| Omnicell Inc. | -10,66 % | 15,03 % | 25,71 % | 28,47 % | -9,28 % | -35,41 % | -70,42 % |
| Myriad Genetics | 0,95 % | -0,64 % | 6,89 % | -38,17 % | -24,17 % | -78,62 % | -83,90 % |
Kommentare
News
Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide
Utah-based Grandeur Peak Global Advisors reduced its stake in Bruker Corporation (NASDAQ:BRKR) by 709,697 shares in the third quarter, contributing to a net position change of $29.54 million
Why Bruker Stock Slumped Monday
Bruker (NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the company's stock took something of a hit. Its price fell nearly 1% by the
Why This Investment Advisor Sold Off Its $3.6 Million Bruker Stake
On Tuesday, Massachusetts-based Lane Generational disclosed that it sold out of Bruker (NASDAQ:BRKR), liquidating 87,607 shares for an estimated $3.6 million in the third quarter.
According to a




